产品
编 号:F166572
分子式:C28H22ClF3N6O3
分子量:582.96
产品类型
结构图
CAS No: 1448347-49-6
联系客服
产品详情
生物活性:
Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity.
体内研究:
AG-120 (gavage administration; 50 mg/kg and 150 mg/kg) declines tumor 2-HG concentration rapidly, with maximum inhibition (92.0% and 95.2% at the 50 mg/kg and 150 mg/kg doses, respectively) achieved at -12 h post dose.Animal Model:Female nude BALB/c mice inoculated with HT1080 cells
Dosage:50 mg/kg and 150 mg/kg
Administration:Gavage administration; 50 mg/kg and 150 mg/kg
Result:Showed robust tumor 2-HG reduction in mouse.
体外研究:
Ivosidenib (AG-120) (0-13 μM; 48 hours) inhibits several IDH1-R132 mutants with potency similar IC50 values: IDH1-R132H (IC50=12 nM); IDH1-R132C (IC50=13 nM); IDH1-R132G (IC50=8 nM); IDH1-R132L (IC50=13 nM); IDH1-R132S (IC50=12 nM), respectively.